Literature DB >> 11880506

Proteolipid protein gene modulates viability and phenotype of neurons.

Shayne E M Boucher1, Maria A Cypher, Leon R Carlock, Robert P Skoff.   

Abstract

Overexpression or lack of expression of proteolipid protein (PLP) gene by oligodendrocytes causes axonal pathology. It is unclear whether dysfunction of the PLP gene mediates its effects directly on neurons or indirectly by abnormal formation of myelin sheaths. We performed experiments using cocultures and conditioned media (CM) to test the direct effect of PLP gene expression on neurons. Non-glial cell lines were stably transfected with PLP or DM20 (an alternate splice variant of PLP) cDNAs. Immunocytochemistry and enhanced green fluorescent protein expression showed that translated products were synthesized and inserted into the plasma membrane in proper conformation. The number of surviving dorsal root ganglion (DRG) neurons was significantly less than controls when cocultured for 5 d with PLP-expressing cells. The number of degenerating neurons increased in a dose-dependent manner corresponding to increasing numbers of PLP-expressing cells. However, the number of surviving DRG neurons cocultured with DM20-expressing cells was comparable to that of controls, indicating that PLP-specific products contributed to decreased neuron survival. When DRG neurons were cultured with CM from PLP- or DM20-expressing cells, significantly fewer neurons survived with CM of PLP- but not DM20-expressing cells. This suggests that secreted factors from PLP-expressing cells contribute to neuronal death. Increased neuronal death found with PLP-expressing cells cannot be attributed to density-dependent artifacts, because in each experiment the density of different cell lines was similar. This effect of CM may be mediated by a negative pH shift elicited from PLP but not DM20 expression. These results indicate that PLP gene products directly modulate neuron viability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880506      PMCID: PMC6758887     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin.

Authors:  M Yoshida; D R Colman
Journal:  Neuron       Date:  1996-06       Impact factor: 17.173

2.  Ionophoric properties of the proteolipid apoprotein from bovine brain myelin.

Authors:  M de Cózar; M Lucas; J Monreal
Journal:  Biochem Int       Date:  1987-05

Review 3.  Axonal pathology in myelin disorders.

Authors:  C Bjartmar; X Yin; B D Trapp
Journal:  J Neurocytol       Date:  1999 Apr-May

4.  Oligodendrocyte proliferation and CNS myelination in cultures containing dissociated embryonic neuroglia and dorsal root ganglion neurons.

Authors:  P M Wood; A K Williams
Journal:  Brain Res       Date:  1984-02       Impact factor: 3.252

5.  Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons.

Authors:  E R Bongarzone; C W Campagnoni; K Kampf; E C Jacobs; V W Handley; V Schonmann; A T Campagnoni
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

6.  The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis.

Authors:  M K Lee; J B Tuttle; L I Rebhun; D W Cleveland; A Frankfurter
Journal:  Cell Motil Cytoskeleton       Date:  1990

Review 7.  The dysmyelinating mouse mutations shiverer (shi) and myelin deficient (shimld).

Authors:  C Readhead; L Hood
Journal:  Behav Genet       Date:  1990-03       Impact factor: 2.805

8.  Proteolipid protein interactions in transfectants: implications for myelin assembly.

Authors:  M P Sinoway; K Kitagawa; S Timsit; G A Hashim; D R Colman
Journal:  J Neurosci Res       Date:  1994-04-01       Impact factor: 4.164

9.  Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport.

Authors:  A Gow; V L Friedrich; R A Lazzarini
Journal:  J Neurosci Res       Date:  1994-04-01       Impact factor: 4.164

10.  Expression of proteolipid protein gene is directly associated with secretion of a factor influencing oligodendrocyte development.

Authors:  J Nakao; M Yamada; T Kagawa; S U Kim; Y Miyao; K Shimizu; K Mikoshiba; K Ikenaka
Journal:  J Neurochem       Date:  1995-06       Impact factor: 5.372

View more
  10 in total

1.  Spinal cord transcriptome analysis using suppression subtractive hybridization and mirror orientation selection.

Authors:  Kanan B Lathia; Zhi Yan; Patric A Clapshaw
Journal:  Cell Mol Neurobiol       Date:  2006-04-18       Impact factor: 5.046

Review 2.  Glial cells: old cells with new twists.

Authors:  Ugo Ndubaku; Maria Elena de Bellard
Journal:  Acta Histochem       Date:  2007-12-18       Impact factor: 2.479

Review 3.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.

Authors:  Sunita Appikatla; Denise Bessert; Icksoo Lee; Maik Hüttemann; Chadwick Mullins; Mallika Somayajulu-Nitu; Fayi Yao; Robert P Skoff
Journal:  Glia       Date:  2013-12-31       Impact factor: 7.452

5.  Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.

Authors:  Anders A F Sima; Christopher R Pierson; Randall L Woltjer; Grace M Hobson; Jeffrey A Golden; William J Kupsky; Galen M Schauer; Thomas D Bird; Robert P Skoff; James Y Garbern
Journal:  Acta Neuropathol       Date:  2009-06-27       Impact factor: 17.088

Review 6.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

7.  Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases.

Authors:  Fanny Mochel; Nadège Boildieu; Julie Barritault; Catherine Sarret; Eleonore Eymard-Pierre; François Seguin; Raphael Schiffmann; Odile Boespflug-Tanguy
Journal:  Biochim Biophys Acta       Date:  2010-07-13

8.  Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.

Authors:  Mallika Somayajulu; Denise A Bessert; Maik Hüttemann; Jasloveleen Sohi; John Kamholz; Robert P Skoff
Journal:  Neurosci Lett       Date:  2018-05-02       Impact factor: 3.046

9.  Different proteolipid protein mutants exhibit unique metabolic defects.

Authors:  Maik Hüttemann; Zhan Zhang; Chadwick Mullins; Denise Bessert; Icksoo Lee; Klaus-Armin Nave; Sunita Appikatla; Robert P Skoff
Journal:  ASN Neuro       Date:  2009-08-25       Impact factor: 4.146

10.  Genome wide association and linkage analyses identified three loci-4q25, 17q23.2, and 10q11.21-associated with variation in leukocyte telomere length: the Long Life Family Study.

Authors:  Joseph H Lee; Rong Cheng; Lawrence S Honig; Mary Feitosa; Candace M Kammerer; Min S Kang; Nicole Schupf; Shiow J Lin; Jason L Sanders; Harold Bae; Todd Druley; Thomas Perls; Kaare Christensen; Michael Province; Richard Mayeux
Journal:  Front Genet       Date:  2014-01-17       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.